What is Tesamorelin?

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), designed to mimic endogenous GHRH activity in laboratory research. It consists of a 44-amino acid peptide sequence that selectively binds to GHRH receptors, making it a useful tool in the study of endocrine pathways, peptide-receptor signalling, and metabolic peptide interactions. Tesamorelin from Power Peptides is provided in lyophilised form at ≥98% purity for in vitro research use only.

Research Applications

• Investigation of GHRH receptor pathway modulation
• In vitro peptide signalling analysis
• Studies on metabolic peptide activity
• Comparative receptor affinity research

Key Features

• Available in 5 mg and 10 mg research vials
• Research-grade purity: ≥98% (HPLC)
• Lyophilised formulation ensures stability
• Batch traceability with Certificate of Analysis available

Specifications

Reconstitution & Handling

• Reconstitute using bacteriostatic water for laboratory use
• Swirl gently to dissolve; avoid agitation
• Aliquot when necessary to maintain integrity throughout storage

Quality & Testing

Tesamorelin from Power Peptides is verified using high-performance liquid chromatography (HPLC) and mass spectrometry to confirm molecular identity and ≥98% purity. Each batch is fully traceable with COA documentation.

Important Notice

For laboratory research use only. Not for human consumption, diagnostic use, therapeutic procedures, or veterinary application.